Skip to main content
Maegan L. Sheehan on Muck Rack

Maegan L. Sheehan

As seen in: MDPI, BioRxiv, Cell Press, Cell Reports Medicine, medRxiv, Gastrointestinal Endoscopy, Pharma Focus Asia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maegan L.

Contact Maegan L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Su1604 SUSTAINED HUMORAL AND CELLULAR IMMUNE RESPONSES FOLLOWING UPDATED COVID-19 BOOSTER VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE SHIELD STUDY

|
By Mary S. Hayney, Brian Fisher, Jennifer Oru, Freddy Caldera, Brian Fisher, Maegan L. Sheehan, Andrew Black, Brian Necela, Keith Knutson, Timothy G. Ritter, Francis A. Farraye, Jennifer Oru, Melinda Dollar-Wilson, Parisa Bakshi
| Gastrointestinal Endoscopy Verified
Also available on ScienceDirect
Open in Who Shared Issue with article?

HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice

|
By Nicolas M.S. Galvez, Adam Nitido, Yi Cao, Cailin E Deal, Christine L. Boutros, Scott MacDonald, Scott Macdonald, Evan C. Lam, Maegan L. Sheehan, Dylan Parsons, Allen Lin, Martin J. Deymier, Jacqueline M. Brady, Benjamin Moon, Christopher Bullock, Amarendra Pegu, Xuejun Chen, Cuiping Liu, Richard A. Koup, John R. Mascola, Vladimir Vrbanac, Daniel Lingwood, Alejandro B Balazs, Seo Bin Yoo, Yentli E. Soto Albrecht, Serah Tanno
| Cell Press Verified
Keywords vectored immunotherapy HIV broadly neutralizing antibody humanized mice AAV evolution resistance fitness escapability Get full text access Log in, subscribe or purchase for full access. References 1. Landovitz, R.J. ∙ Scott, H. ∙ Deeks, S.G. Prevention, treatment and cure of HIV infection Nat. Rev. Microbiol. 2023; 21:657-670 2. Bekker, L.-G. ∙ Das, M. ∙ Abdool Karim, Q. ... Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women N. Engl. J. Med. 2024; 391:1179-1192 3.
Open in Who Shared Issue with article?

Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues

|
By Devin Kenney, Anna Tseng, Jacquelyn Turcinovic, Maegan L. Sheehan
| Pharma Focus Asia
Devin Kenney, Aoife K. O’Connell, Anna E. Tseng, Jacquelyn Turcinovic, Maegan L. Sheehan, Adam D. Nitido, Paige Montanaro, Hans P. Gertje, Maria Ericsson, John H. Connor, Vladimir Vrbanac, Nicholas A. Crossland, Christelle Harly, Alejandro B. Balazs, Florian Douam.
Open in Who Shared Issue with article?
See all 8 articles